USTRs Out of Cycle Review of IPR issues in India to end in two weeks
@TheDollarBiz Every third tablet consumed in the World is ‘Made in India’ - Indian Drugs Manufacturers' Association (IDMA) As planned earlier this year, the US Trade Representative (USTR) has started an Out-of-Cycle Review (OCR) of India for its 301 paper (Section 301 of the US Trade Act of 1974) which has India on a “Priority Watch List” on issues concerning protection of US Intellectual Property Rights (IPR) in India. The first 301 report, then called a “Fact Sheet,” was published in 1989 and had eight countries on the "Priority Watch List" and 17 on the "Watch List". Since then, countries such as Italy, South Korea and the Philippines have been removed from the lists, but India remains stuck, mainly due ...
